Search Clinical Trials
598,193 trials
ID
Status
Phase
Title
Sponsor
NCT07762833
Randomized, Double-blind, Placebo-controlled Study of Nemolizumab in Chinese Subjects With Moderate-to-severe Atopic DermatitisGalderma R&DNot Yet RecruitingPhase 3
NCT07762833Not Yet Recruiting
Phase 3
Randomized, Double-blind, Placebo-controlled Study of Nemolizumab in Chinese Sub...Galderma R&D
NCT07762885
Omission of Adjuvant Radiotherapy in Low- and Intermediate-Risk Ductal Carcinoma In Situ After Breast-Conserving SurgeryFudan UniversityRecruitingPhase 3
NCT07762885Recruiting
Phase 3
Omission of Adjuvant Radiotherapy in Low- and Intermediate-Risk Ductal Carcinoma...Fudan University
NCT07762248
Impact of Minimally Invasive Endodontic Treatment on the Prognosis of Mandibular Permanent Molars With Necrotic Pulp and Apical PeriodontitisMohamed Ashraf AbdeenNot Yet RecruitingPhase 2
NCT07762248Not Yet Recruiting
Phase 2
Impact of Minimally Invasive Endodontic Treatment on the Prognosis of Mandibular...Mohamed Ashraf Abdeen
NCT07762183
Dependence, Frailty, and Kinesiophobia on Early Postoperative Mobilization and Self-Care Ability in Patients Undergoing Lumbar Disc Herniation SurgeryAydin Adnan Menderes UniversityCompleted
NCT07762183Completed
—
Dependence, Frailty, and Kinesiophobia on Early Postoperative Mobilization and S...Aydin Adnan Menderes Univ...
NCT07761962
Laser Assisted Pulpotomy Versus MTA Pulpotomy in Permanent Teeth With Irreversible PulpitisKing Abdullah University HospitalActive Not RecruitingNot Applicable
NCT07761962Active Not Recruiting
Not Applicable
Laser Assisted Pulpotomy Versus MTA Pulpotomy in Permanent Teeth With Irreversib...King Abdullah University...
NCT07762001
Phase 1 Single-blind Placebo-controlled Dose Escalation Safety Study of AD-NP1Arjun Deb, MDActive Not RecruitingPhase 1
NCT07762001Active Not Recruiting
Phase 1
Phase 1 Single-blind Placebo-controlled Dose Escalation Safety Study of AD-NP1Arjun Deb, MD
NCT07763366
Pain Neuroscience Education and Graded Motor Imagery Combined With Conventional Physiotherapy on Diabetic Adhesive CapsulitisRiphah International UniversityNot Yet RecruitingNot Applicable
NCT07763366Not Yet Recruiting
Not Applicable
Pain Neuroscience Education and Graded Motor Imagery Combined With Conventional...Riphah International Univ...
NCT07763678
Efficacy of Ultrasound-Guided Combined Greater Occipital Nerve Block and Greater Auricular Nerve Block Versus Greater Occipital Nerve Block Alone in the Management of Chronic MigraineAssiut UniversityNot Yet RecruitingPhase 4
NCT07763678Not Yet Recruiting
Phase 4
Efficacy of Ultrasound-Guided Combined Greater Occipital Nerve Block and Greater...Assiut University
NCT07764146
An Open Label Dose Escalation Study of VY1706 in Participants With Early Alzheimer's DiseaseVoyager TherapeuticsNot Yet RecruitingPhase 1
NCT07764146Not Yet Recruiting
Phase 1
An Open Label Dose Escalation Study of VY1706 in Participants With Early Alzheim...Voyager Therapeutics
NCT07762690
Mechanism-Based Cervical Rehabilitation for Chronic MigraineBeni-Suef UniversityNot Yet RecruitingNot Applicable
NCT07762690Not Yet Recruiting
Not Applicable
Mechanism-Based Cervical Rehabilitation for Chronic MigraineBeni-Suef University
NCT07763990
THE EVALUATION OF THE SAFETY AND PERFORMANCE OF AN INJECTABLE HYALURONIC ACID FILLERHallura Ltd.RecruitingNot Applicable
NCT07763990Recruiting
Not Applicable
THE EVALUATION OF THE SAFETY AND PERFORMANCE OF AN INJECTABLE HYALURONIC ACID FI...Hallura Ltd.
NCT07763756
Single vs Multiple Injection Intertransverse Process Block in Breast Cancer SurgeryAntalya City HospitalNot Yet RecruitingNot Applicable
NCT07763756Not Yet Recruiting
Not Applicable
Single vs Multiple Injection Intertransverse Process Block in Breast Cancer Surg...Antalya City Hospital
NCT07763938
CD19/CD20 Dual-Target in Vivo CAR-T Lentiviral Product in the Treatment of Relapsed/Refractory B-cell MalignanciesNanjing Legend Biotech Co.Not Yet RecruitingPhase 1
NCT07763938Not Yet Recruiting
Phase 1
CD19/CD20 Dual-Target in Vivo CAR-T Lentiviral Product in the Treatment of Relap...Nanjing Legend Biotech Co...
NCT07762040
Predictors of Progression Independent of Relapse Activity in Relapsing Remitting Multiple SclerosisAssiut UniversityNot Yet Recruiting
NCT07762040Not Yet Recruiting
—
Predictors of Progression Independent of Relapse Activity in Relapsing Remitting...Assiut University
NCT07762963
Turkish Validation of the Core Life Activities ScaleTokat Gaziosmanpasa UniversityNot Yet Recruiting
NCT07762963Not Yet Recruiting
—
Turkish Validation of the Core Life Activities ScaleTokat Gaziosmanpasa Unive...
NCT07764302
Enhancing Amoxicillin Pharmacokinetics and Pharmacodynamics Parameters With Probenecid in Bone and Joint InfectionsAssistance Publique - Hôpitaux de ParisNot Yet RecruitingPhase 3
NCT07764302Not Yet Recruiting
Phase 3
Enhancing Amoxicillin Pharmacokinetics and Pharmacodynamics Parameters With Prob...Assistance Publique - Hôp...
NCT07762261
Impact of Generative AI on University Students' Learning Processes and Critical ThinkingAtaturk UniversityNot Yet RecruitingNot Applicable
NCT07762261Not Yet Recruiting
Not Applicable
Impact of Generative AI on University Students' Learning Processes and Critical...Ataturk University
NCT07762339
Comparison of Erector Spinae Plane Block and Caudal Block for Postoperative Analgesia in Pediatric Patients Undergoing Orchiopexy: A Prospective Observational StudyProf. Dr. Cemil Tascıoglu Education and Research Hospital OrganizationRecruiting
NCT07762339Recruiting
—
Comparison of Erector Spinae Plane Block and Caudal Block for Postoperative Anal...Prof. Dr. Cemil Tascıoglu...
NCT07762209
Papilozumib Vaginal Gel for Exocervical Mucosal Restoration in Women With HPVAdknoma Health ResearchNot Yet RecruitingNot Applicable
NCT07762209Not Yet Recruiting
Not Applicable
Papilozumib Vaginal Gel for Exocervical Mucosal Restoration in Women With HPVAdknoma Health Research
Result Breakdown
Not yet recruiting13 (65%)
Recruiting4 (20%)
Active, not recruiting2 (10%)
Completed1 (5%)
not_applicable7 (35%)
Not Specified5 (25%)
Phase 33 (15%)
Phase 13 (15%)
Phase 21 (5%)
Phase 41 (5%)